364 related articles for article (PubMed ID: 34655640)
1. Advances in asthma: New understandings of asthma's natural history, risk factors, underlying mechanisms, and clinical management.
Miller RL; Grayson MH; Strothman K
J Allergy Clin Immunol; 2021 Dec; 148(6):1430-1441. PubMed ID: 34655640
[TBL] [Abstract][Full Text] [Related]
2. Advances in asthma in 2017: Mechanisms, biologics, and genetics.
Grayson MH; Feldman S; Prince BT; Patel PJ; Matsui EC; Apter AJ
J Allergy Clin Immunol; 2018 Nov; 142(5):1423-1436. PubMed ID: 30213625
[TBL] [Abstract][Full Text] [Related]
3. Asthma from immune pathogenesis to precision medicine.
Khalaf K; Paoletti G; Puggioni F; Racca F; De Luca F; Giorgis V; Canonica GW; Heffler E
Semin Immunol; 2019 Dec; 46():101294. PubMed ID: 31387788
[TBL] [Abstract][Full Text] [Related]
4. New Treatments for Asthma.
Huang J; Pansare M
Pediatr Clin North Am; 2019 Oct; 66(5):925-939. PubMed ID: 31466682
[TBL] [Abstract][Full Text] [Related]
5. Current and future targeted therapies for severe asthma: Managing treatment with biologics based on phenotypes and biomarkers.
Santus P; Saad M; Damiani G; Patella V; Radovanovic D
Pharmacol Res; 2019 Aug; 146():104296. PubMed ID: 31173886
[TBL] [Abstract][Full Text] [Related]
6. Childhood asthma heterogeneity at the era of precision medicine: Modulating the immune response or the microbiota for the management of asthma attack.
Lejeune S; Deschildre A; Le Rouzic O; Engelmann I; Dessein R; Pichavant M; Gosset P
Biochem Pharmacol; 2020 Sep; 179():114046. PubMed ID: 32446884
[TBL] [Abstract][Full Text] [Related]
7. The relationship between allergen immunotherapy and omalizumab for treating asthma.
Braido F; Corsico A; Rogkakou A; Ronzoni V; Baiardini I; Canonica GW
Expert Rev Respir Med; 2015 Apr; 9(2):129-34. PubMed ID: 25578528
[TBL] [Abstract][Full Text] [Related]
8. Recent Advances in Severe Asthma: From Phenotypes to Personalized Medicine.
Schoettler N; Strek ME
Chest; 2020 Mar; 157(3):516-528. PubMed ID: 31678077
[TBL] [Abstract][Full Text] [Related]
9. Biological treatments for severe asthma.
Assaf SM; Hanania NA
Curr Opin Allergy Clin Immunol; 2019 Aug; 19(4):379-386. PubMed ID: 31169594
[TBL] [Abstract][Full Text] [Related]
10. [New guidelines and new therapy options in severe asthma].
Einecke D
MMW Fortschr Med; 2016 May; 158(9):18-9. PubMed ID: 27155682
[No Abstract] [Full Text] [Related]
11. Drug Development and Biologics in Asthma. A New Era.
Doyle R
Ann Am Thorac Soc; 2016 Mar; 13 Suppl 1():S83-4. PubMed ID: 27027958
[TBL] [Abstract][Full Text] [Related]
12. Biologics and biomarkers for asthma, urticaria, and nasal polyposis.
Casale TB
J Allergy Clin Immunol; 2017 May; 139(5):1411-1421. PubMed ID: 28477720
[TBL] [Abstract][Full Text] [Related]
13. How to compare the efficacy of biologic agents in asthma.
Viswanathan RK; Busse WW
Ann Allergy Asthma Immunol; 2020 Aug; 125(2):137-149. PubMed ID: 32387169
[TBL] [Abstract][Full Text] [Related]
14. Guiding principles for use of newer biologics and bronchial thermoplasty for patients with severe asthma.
Blaiss MS; Castro M; Chipps BE; Zitt M; Panettieri RA; Foggs MB
Ann Allergy Asthma Immunol; 2017 Dec; 119(6):533-540. PubMed ID: 29103801
[TBL] [Abstract][Full Text] [Related]
15. Immune mechanisms and development of childhood asthma.
Raedler D; Schaub B
Lancet Respir Med; 2014 Aug; 2(8):647-56. PubMed ID: 25008972
[TBL] [Abstract][Full Text] [Related]
16. Controversies and opportunities in severe asthma.
Humbert M; Busse W; Hanania NA
Curr Opin Pulm Med; 2018 Jan; 24(1):83-93. PubMed ID: 29059087
[TBL] [Abstract][Full Text] [Related]
17. Molecular Targets for Biological Therapies of Severe Asthma.
Pelaia C; Crimi C; Vatrella A; Tinello C; Terracciano R; Pelaia G
Front Immunol; 2020; 11():603312. PubMed ID: 33329598
[TBL] [Abstract][Full Text] [Related]
18. Biologics in asthma--the next step toward personalized treatment.
Darveaux J; Busse WW
J Allergy Clin Immunol Pract; 2015; 3(2):152-60; quiz 161. PubMed ID: 25754716
[TBL] [Abstract][Full Text] [Related]
19. Emerging Biologics in Severe Asthma.
Pavord ID; Hilvering B; Shrimanker R
Immunol Allergy Clin North Am; 2016 Aug; 36(3):609-23. PubMed ID: 27401629
[TBL] [Abstract][Full Text] [Related]
20. Personalized medicine with biologics for severe type 2 asthma: current status and future prospects.
Godar M; Blanchetot C; de Haard H; Lambrecht BN; Brusselle G
MAbs; 2018 Jan; 10(1):34-45. PubMed ID: 29035619
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
